AI assistant
Sending…
RESMED INC — Director's Dealing 2018
Nov 14, 2018
30071_dirs_2018-11-13_9d8ad954-0f68-4cb9-b92d-030159957e76.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2018-11-09
Reporting Person: Douglas Robert Andrew (President and COO ResMed Inc.)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-11-09 | ResMed Common Stock | F | 2018 | $106.94 | Disposed | 61799 | Direct |
| 2018-11-09 | ResMed Common Stock | F | 5994 | $106.94 | Disposed | 55805 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| ResMed Common Stock | 110206 | Indirect |
Footnotes
F1: Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/16/2017.
F2: Includes 128.63 shares of ResMed stock purchased on October 31, 2018, through the ResMed Employee Stock Purchase Plan.
F3: Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/16/2016.
More from RESMED INC
Regulatory Filings
2026
May 26
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 10
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 3
Interim / Quarterly Report
2026
Jan 30
Earnings Release
2026
Jan 29